Advertisement ABL signs patent licensing agreement with Viralliance - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

ABL signs patent licensing agreement with Viralliance

ABL Patent Licensing Technologies, a subsidiary of Advanced Biological Laboratories, has entered into a patent licensing agreement with Viralliance.

As per the terms of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to Viralliance to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient.